Clinical trials
Phase 2 trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
705 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 17 |
| 2001 | 9 |
| 2002 | 10 |
| 2003 | 11 |
| 2004 | 13 |
| 2005 | 14 |
| 2006 | 19 |
| 2007 | 22 |
| 2008 | 26 |
| 2009 | 29 |
| 2010 | 29 |
| 2011 | 37 |
| 2012 | 23 |
| 2013 | 11 |
| 2014 | 21 |
| 2015 | 15 |
| 2016 | 17 |
| 2017 | 25 |
| 2018 | 25 |
| 2019 | 33 |
| 2020 | 40 |
| 2021 | 43 |
| 2022 | 31 |
| 2023 | 30 |
| 2024 | 36 |
| 2025 | 24 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 482 |
| Active, not recruiting | 74 |
| Terminated | 70 |
| Recruiting | 56 |
| Unknown status | 16 |
| Withdrawn | 4 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 67 |
| National Cancer Institute (NCI) | 66 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 60 |
| Children's Oncology Group | 35 |
| Gilead Sciences | 31 |
| AbbVie | 26 |
| Bristol-Myers Squibb | 26 |
| Hoffmann-La Roche | 23 |
| GlaxoSmithKline | 19 |
| Pfizer | 17 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 85 |
| Hepatitis C | 45 |
| Non-alcoholic Fatty Liver Disease | 43 |
| Diabetes Mellitus, Type 2 | 42 |
| Acquired Immunodeficiency Syndrome | 34 |
| Hepatitis C, Chronic | 28 |
| Sarcoma | 23 |
| Lymphoma, Non-Hodgkin | 22 |
| Arthritis, Rheumatoid | 20 |
| Neuroectodermal Tumors, Primitive, Peripheral | 20 |
Trials
Showing 26 to 50 of 705. Each trial links to its page on Pharma Observatory.
605 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.